• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝移植中的 Eurotransplant 供者风险指数:ET-DRI。

The Eurotransplant donor risk index in liver transplantation: ET-DRI.

机构信息

Department of Transplant Surgery, Leiden University Medical Center, Leiden, the Netherlands.

出版信息

Am J Transplant. 2012 Oct;12(10):2789-96. doi: 10.1111/j.1600-6143.2012.04195.x. Epub 2012 Jul 23.

DOI:10.1111/j.1600-6143.2012.04195.x
PMID:22823098
Abstract

Recently we validated the donor risk index (DRI) as conducted by Feng et al. for the Eurotransplant region. Although this scoring system is a valid tool for scoring donor liver quality, for allocation purposes a scoring system tailored for the Eurotransplant region may be more appropriate. Objective of our study was to investigate various donor and transplant risk factors and design a risk model for the Eurotransplant region. This study is a database analysis of all 5939 liver transplantations from deceased donors into adult recipients from the 1st of January 2003 until the 31st of December 2007 in Eurotransplant. Data were analyzed with Kaplan-Meier and Cox regression models. From 5723 patients follow-up data were available with a mean of 2.5 years. After multivariate analysis the DRI (p < 0.0001), latest lab GGT (p = 0.005) and rescue allocation (p = 0.007) remained significant. These factors were used to create the Eurotransplant Donor Risk Index (ET-DRI). Concordance-index calculation shows this ET-DRI to have high predictive value for outcome after liver transplantation. Therefore, we advise the use of this ET-DRI for risk indication and possibly for allocation purposes within the Eurotrans-plant region.

摘要

最近,我们验证了 Feng 等人提出的供体风险指数 (DRI) 在 Eurotransplant 区域的适用性。虽然该评分系统是评估供体肝质量的有效工具,但对于分配目的而言,为 Eurotransplant 区域量身定制的评分系统可能更为合适。本研究的目的是调查各种供体和移植风险因素,并为 Eurotransplant 区域设计一个风险模型。这是一项对 2003 年 1 月 1 日至 2007 年 12 月 31 日期间 Eurotransplant 中 5939 例来自已故供体的成人受体肝移植的数据库分析。数据采用 Kaplan-Meier 和 Cox 回归模型进行分析。在 5723 例患者中,有 5723 例患者可获得随访数据,平均随访时间为 2.5 年。经过多变量分析,DRI(p < 0.0001)、最新实验室 GGT(p = 0.005)和抢救性分配(p = 0.007)仍然具有统计学意义。这些因素被用于创建 Eurotransplant 供体风险指数 (ET-DRI)。一致性指数计算表明,该 ET-DRI 对肝移植后结局具有较高的预测价值。因此,我们建议在 Eurotransplant 区域内使用该 ET-DRI 进行风险指示,并且可能用于分配目的。

相似文献

1
The Eurotransplant donor risk index in liver transplantation: ET-DRI.肝移植中的 Eurotransplant 供者风险指数:ET-DRI。
Am J Transplant. 2012 Oct;12(10):2789-96. doi: 10.1111/j.1600-6143.2012.04195.x. Epub 2012 Jul 23.
2
Combined effect of donor and recipient risk on outcome after liver transplantation: Research of the Eurotransplant database.供体和受体风险对肝移植术后结局的联合影响:欧洲移植数据库研究
Liver Transpl. 2015 Dec;21(12):1486-93. doi: 10.1002/lt.24308.
3
Validation of the donor risk index in orthotopic liver transplantation within the Eurotransplant region.供体风险指数在欧洲器官移植区域内原位肝移植中的验证。
Liver Transpl. 2012 Jan;18(1):112-9. doi: 10.1002/lt.22447.
4
Prognostic limitations of the Eurotransplant-Donor Risk Index in liver transplantation.欧洲移植供体风险指数在肝移植中的预后局限性
J Negat Results Biomed. 2013 Dec 24;12:18. doi: 10.1186/1477-5751-12-18.
5
The center effect in liver transplantation in the Eurotransplant region: a retrospective database analysis.肝移植中欧洲器官移植中心的中心效应:一项回顾性数据库分析。
Transpl Int. 2018 Jun;31(6):610-619. doi: 10.1111/tri.13129. Epub 2018 Mar 5.
6
External validation of the Donor Risk Index and the Eurotransplant Donor Risk Index on the French liver transplantation registry.法国肝移植注册中心对供体风险指数和 Eurotransplant 供体风险指数的外部验证。
Liver Int. 2017 Aug;37(8):1229-1238. doi: 10.1111/liv.13378. Epub 2017 Feb 23.
7
Eurotransplant donor-risk-index and recipient factors: influence on long-term outcome after liver transplantation - A large single-center experience.欧洲移植供体风险指数及受者因素:对肝移植术后长期结局的影响——一项大型单中心经验
Clin Transplant. 2016 May;30(5):508-17. doi: 10.1111/ctr.12714. Epub 2016 Mar 16.
8
Prognostic role of the Donor Risk Index, the Eurotransplant Donor Risk Index, and the Balance of Risk score on graft loss after liver transplantation.供者风险指数、欧洲肝移植供者风险指数和风险平衡评分对肝移植后移植物丢失的预后作用。
Transpl Int. 2021 May;34(5):778-800. doi: 10.1111/tri.13861. Epub 2021 May 1.
9
Impact of the donor risk index on the outcome of hepatitis C virus-positive liver transplant recipients.供体风险指数对丙型肝炎病毒阳性肝移植受者结局的影响。
Liver Transpl. 2009 Jun;15(6):592-9. doi: 10.1002/lt.21699.
10
The interaction among donor characteristics, severity of liver disease, and the cost of liver transplantation.供体特征、肝病严重程度和肝移植成本之间的相互作用。
Liver Transpl. 2011 Mar;17(3):233-42. doi: 10.1002/lt.22230.

引用本文的文献

1
Addition of a Temporary Portocaval Shunt Does Not Reduce Acute Kidney Injury in Caval-Sparing Liver Transplantation.增加临时性门腔分流术并不能降低保留腔静脉肝移植中的急性肾损伤发生率。
Clin Transplant. 2025 Aug;39(8):e70259. doi: 10.1111/ctr.70259.
2
Risk factors associated with adverse cardiovascular events during orthotopic liver transplantation and the early post-transplant period.原位肝移植及移植后早期与不良心血管事件相关的危险因素。
Croat Med J. 2025 Jul 5;66(3):194-203.
3
Prolonged allograft survival in liver transplantation.肝移植中同种异体移植物的长期存活
Surg Open Sci. 2025 Mar 28;25:8-13. doi: 10.1016/j.sopen.2025.03.006. eCollection 2025 Apr.
4
Protocol for an international multicenter, prospective, observational, non-competitive, study to validate and optimise prediction models of 90-day and 1-year allograft failure after liver transplantation: The global IMPROVEMENT Study.一项国际多中心、前瞻性、观察性、非竞争性研究的方案,旨在验证和优化肝移植后90天和1年同种异体移植物失败的预测模型:全球IMPROVEMENT研究。
Updates Surg. 2025 Mar 27. doi: 10.1007/s13304-025-02078-4.
5
Equal performance of HTK-based and UW-based perfusion solutions in sub-normothermic liver machine perfusion.基于HTK和基于UW的灌注液在亚低温肝脏机器灌注中的性能相当。
Sci Rep. 2025 Mar 4;15(1):7601. doi: 10.1038/s41598-025-90799-2.
6
Perspectives and Tools in Liver Graft Assessment: A Transformative Era in Liver Transplantation.肝脏移植评估的视角与工具:肝脏移植的变革时代
Biomedicines. 2025 Feb 17;13(2):494. doi: 10.3390/biomedicines13020494.
7
A biomarker framework for liver aging: the Aging Biomarker Consortium consensus statement.肝脏衰老的生物标志物框架:衰老生物标志物联盟共识声明。
Life Med. 2024 Jan 30;3(1):lnae004. doi: 10.1093/lifemedi/lnae004. eCollection 2024 Feb.
8
Real-Time Biomarkers of Liver Graft Quality in Hypothermic Oxygenated Machine Perfusion.低温氧合机器灌注中肝脏移植质量的实时生物标志物
J Clin Med. 2025 Jan 13;14(2):471. doi: 10.3390/jcm14020471.
9
Impact of Resuscitated Cardiac Arrest in the Brain-dead Donors on the Outcome of Liver Transplantation: A Retrospective and Propensity Score Matching Analysis.脑死亡供体中复苏后心脏骤停对肝移植结局的影响:一项回顾性和倾向评分匹配分析
Ann Surg Open. 2024 Nov 25;5(4):e522. doi: 10.1097/AS9.0000000000000522. eCollection 2024 Dec.
10
Expression of sPD-L1 levels in an ex vivo liver perfusion model.离体肝脏灌注模型中可溶性程序性死亡受体配体-1(sPD-L1)水平的表达
Clin Exp Immunol. 2025 Jan 21;219(1). doi: 10.1093/cei/uxae094.